ArticleThe Journal of clinical investigation2022

CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome.

Silvia Arcangeli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.